5-Aminolevulinic acid photodynamic therapy and isotretinoin for treatment of drug-induced acne fulminans in a patient with idiopathic thrombocytopenic purpura

In: Photodiagnosis and Photodynamic Therapy · 2019 · vol. 29 , pp. 101630 · doi:10.1016/j.pdpdt.2019.101630 · PMID:31870898 · W2994882685
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-12

This paper reports the successful treatment of drug-induced acne fulminans in a patient with idiopathic thrombocytopenic purpura using 5-aminolevulinic acid photodynamic therapy combined with isotretinoin.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In this work, we present a case of deteriorative acne that occurred during methylprednisolone and danazol treatment of idiopathic thrombocytopenic purpura (ITP). Treatment of the patient with a combination of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) and isotretinoin was satisfactory, though the patient had platelets as low as 4-10 × 109/L during treatment. We consider that the combination of oral isotretinoin and ALA-PDT was effective in this patient may be due to the synergetic effect of these treatments. To the best of our knowledge, no such cases have been reported.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (6)

SciLite annotations

chemicals 7
5-aminolevulinic acid isotretinoin prednisolone danazol 5-aminolevulinic acid isotretinoin isotretinoin

Source provenance

openalex
last seen: 2026-05-11T06:27:45.971503+00:00
scilite
last seen: 2026-05-18T04:26:01.642840+00:00
License: CC0 · commercial use OK